Development of a 3D Skin Model for Studying Melanoma Progression
Cells · 23.02.2026 · 15 (4) · 379
DOI: 10.3390/cells15040379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 23.02.2026. Verfasst von Dragana P C de Barros und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Tecnologia Química e Biológica António Xavier, NOVA University Lisbon, 2780-157 Oeiras, Portugal. Hauptthemen laut MEDLINE: Melanoma, Disease Progression, Models, Biological, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, LS4FUTUREAssociated Laboratory, Henrique Meirelles.
Abstract (Originalsprache)
Despite advances in the treatment of cutaneous melanoma, there is still a high percentage of patients who fail to respond or develop resistance to treatment. Establishing robust in vitro melanoma models will enable mechanism-based drug screening while reducing animal testing. In this work, a three-dimensional (3D) melanoma skin model (3DMSM) was developed on a porous scaffold. The culture of three melanoma cell lines (SKMEL-1, A375, and G361) in co-culture with human fibroblasts, melanocytes, and keratinocytes allowed the formation of the dermis, and stratified epidermis. Tumors were established in this model using two methodologies: adding previously formed melanoma cell aggregates (CA) or seeding melanoma cells directly into the dermis (CD). In this model, melanoma cells remain in their original microenvironment and, after proliferation, invade the basal layer. The model recapitulates correct melanocyte localization, epidermal disruption, extracellular matrix (ECM) remodeling, including collagen deposition, and epithelial-to-mesenchymal transition (EMT). Additionally, the cytokine profiles studied indicate that the model could mirror the inflammatory and immune-evasive traits of melanoma. Overall, 3DMSM provides a useful tool for understanding the mechanisms of melanoma progression and invasion, and for developing personalized medicine strategies through the implementation of a patient-derived model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto de Tecnologia Química e Biológica António Xavier, NOVA University Lisbon, 2780-157 Oeiras, Portugal.
- Hidrodipro, Produtos Químicos e Farmaceuticos, Rua Quinta das Lamas, s/n, 1675-190 Pontinha, Portugal.
- Centre for Ecology, Evolution and Environmental Changes (CE3C) & CHANGE, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal.
- Centro Hospitalar de Lisboa Ocidental (CHLO), 1449-005 Lisboa, Portugal.
ORCID-Profile: Dragana P C de Barros, Ana Sofia Lopes, Rita Zilhão, Abel Oliva
Förderung
- Fundação para a Ciência e Tecnologia
- LS4FUTUREAssociated Laboratory
- Henrique Meirelles
- Fundação para a Ciência e a Tecnologia
- iN-OVA4Health
- MATRIHEALTH Project
- Liga Portuguesa Contra o Cancro—Núcleo Regional Sul
- Academia das Ciências de Lisboa
Zitieren
APA
P C de Barros, D., Ventura, S., Duque, M., Ribeiro, V., Lopes, A. S., Zilhão, R., Carlos, A. R., & Oliva, A. (2026). Development of a 3D Skin Model for Studying Melanoma Progression. Cells, 15(4), 379. https://doi.org/10.3390/cells15040379
Vancouver
P C de Barros D, Ventura S, Duque M, Ribeiro V, Lopes AS, Zilhão R, et al. Development of a 3D Skin Model for Studying Melanoma Progression. Cells. 2026;15(4):379. doi:10.3390/cells15040379
BibTeX
@article{PCdeBarros2026,
author = {P C de Barros, Dragana and Ventura, Sara and Duque, Madalena and Ribeiro, Vanessa and Lopes, Ana Sofia and Zilhão, Rita and Carlos, Ana Rita and Oliva, Abel},
title = {Development of a 3D Skin Model for Studying Melanoma Progression},
journal = {Cells},
year = {2026},
volume = {15},
number = {4},
pages = {379},
doi = {10.3390/cells15040379}
}
EUVIMED